Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Frey

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
British Journal of Clinical Pharmacology|March 14, 2019
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapyCandice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, et al.
Clinical Pharmacology and Therapeutics|June 27, 2025
Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHLCandice Jamois, David C Turner, Leonid Gibiansky, et al.
Hepatology (Baltimore, Md.)|April 25, 2018
Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE StudyStefan Wirth, Hongfei Zhang, Winita Hardikar, et al.
Clinical Pharmacology and Therapeutics|May 15, 2021
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot ProgramGerald R Galluppi, Satjit Brar, Luzelena Caro, et al.
Clinical Pharmacology and Therapeutics|August 3, 2023
Model-Informed Drug Development: Steps Toward Harmonized GuidanceScott Marshall, Malidi Ahamadi, Jenny Chien, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
British Journal of Clinical Pharmacology|March 14, 2019
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapyCandice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, et al.
Clinical Pharmacology and Therapeutics|June 27, 2025
Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHLCandice Jamois, David C Turner, Leonid Gibiansky, et al.
Hepatology (Baltimore, Md.)|April 25, 2018
Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE StudyStefan Wirth, Hongfei Zhang, Winita Hardikar, et al.
Clinical Pharmacology and Therapeutics|May 15, 2021
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot ProgramGerald R Galluppi, Satjit Brar, Luzelena Caro, et al.
Clinical Pharmacology and Therapeutics|August 3, 2023
Model-Informed Drug Development: Steps Toward Harmonized GuidanceScott Marshall, Malidi Ahamadi, Jenny Chien, et al.
Pageof 6